Antibody-drug conjugates for urothelial carcinoma
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference54 articles.
1. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol,2000
2. Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924
3. Pembrolizumab as second-line therapy for advanced urothelial carcinoma;Bellmunt;N Engl J Med,2017
4. Avelumab in metastatic urothelial carcinoma after platinum failure (javelin solid tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial;Patel;Lancet Oncol,2018
5. Erdafitinib in locally advanced or metastatic urothelial carcinoma;Loriot;N Engl J Med,2019
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Organ-Specific Tumor Response to Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study;Clinical Genitourinary Cancer;2024-10
2. New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives;International Journal of Molecular Sciences;2024-09-07
3. Antibody-dye Conjugates Targeting EGFR and HER2 for the Photoimmunotherapy of Bladder Cancer;Anticancer Research;2024-04-27
4. Advances in preclinical assessment of therapeutic targets for bladder cancer precision medicine;Current Opinion in Urology;2024-04-10
5. Nectin-4: A promising prognostic marker and therapeutic target in cancer;International Review of Cell and Molecular Biology;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3